Internal Medicine, Nephrology · Baton Rouge, LA
NPI
1922188390
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
5131 Odonovan Dr Ste 100
Baton Rouge, LA, 70808
Phone (225) 767-4893
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
2,061 services
Medicare patients, 2024
435
Average age 70
Drug cost, 2024
$1.2M
1,858 prescriptions
Company payments, 2025
$945
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Damodar R Kumbala was code 99214 (office e&m - established), 199 times for 149 patients. In total Damodar R Kumbala billed 2,061 services in 41 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 199 | 149 | $60.44 | $12K |
| 90960 ESRD Related Services (not dialysis) | Office | 182 | 28 | $275.83 | $50K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 121 | 89 | $12.22 | $1,479 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 112 | 31 | $44.78 | $5,016 |
| 99232 Hospital E&M - Subsequent | Facility | 98 | 62 | $57.61 | $5,646 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 67 | 67 | $71.14 | $4,766 |
| 36902 A-V Fistula PCI | Facility | 45 | 39 | $174.96 | $7,873 |
| 90935 Hemodialysis | Facility | 43 | 36 | $53.02 | $2,280 |
| 90961 ESRD Related Services (not dialysis) | Office | 40 | 21 | $229.45 | $9,178 |
| 99152 Anesthesia | Facility | 33 | 31 | $9.09 | $300 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 25 | 15 | $33.98 | $849 |
| 99222 Hospital E&M - Initial | Facility | 24 | 23 | $97.69 | $2,345 |
| 99153 Anesthesia | Facility | 22 | 15 | $8.03 | $177 |
| 36903 A-V Fistula PCI | Facility | 16 | 16 | $233.38 | $3,734 |
| 99204 Office E&M - New | Office | 15 | 15 | $124.13 | $1,862 |
By year: 2022 $152K for 5,036 services; 2023 $141K for 4,600 services; 2024 $124K for 2,061 services.
Medicare prescription drug claims, 2024
In 2024, the drug Damodar R Kumbala prescribed most often to Medicare patients was Rayaldee (Calcifediol), with 219 prescriptions and refills. In total Damodar R Kumbala wrote 1,858 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rayaldee Calcifediol | 219 | 219 | 31 | $264K |
| Losartan Potassium Generic | 177 | 323 | 47 | $957 |
| Farxiga Dapagliflozin Propanediol | 177 | 229 | 41 | $127K |
| Furosemide Generic | 148 | 230 | 40 | $593 |
| Kerendia Finerenone | 127 | 165 | 20 | $105K |
| Chlorthalidone Generic | 87 | 157 | 26 | $1,041 |
| Jardiance Empagliflozin | 85 | 113 | 22 | $65K |
| Carvedilol Generic | 66 | 112 | 20 | $534 |
| Hydralazine Hcl Generic | 66 | 88 | 14 | $760 |
| Spironolactone Generic | 62 | 113 | 17 | $261 |
| Veltassa Patiromer Calcium Sorbitex | 54 | 65 | 19 | $58K |
| Amlodipine Besylate Generic | 49 | 108 | 22 | $227 |
| Lokelma Sodium Zirconium Cyclosilicate | 48 | 52 | Under 11 | $32K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 40 | 61 | 14 | $228 |
| Potassium Chloride Generic | 39 | 55 | Under 11 | $416 |
Brand drugs: 886 claims; generic drugs: 972 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Damodar R Kumbala $945 ($945 in general payments such as food, travel and fees) from 19 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $251.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $251 |
| Mallinckrodt Hospital Products Inc. | 4 | $144 |
| Fresenius USA Marketing, Inc. | 4 | $93.26 |
| Calliditas Therapeutics US Inc. | 3 | $78.75 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $56.04 |
| Novo Nordisk Inc NVO | 2 | $40.64 |
| Lilly USA, LLC LLY | 2 | $39.72 |
| OPKO Pharmaceuticals, LLC | 2 | $35.74 |
| Akebia Therapeutics Inc AKBA | 1 | $29.38 |
| W. L. Gore & Associates, Inc. | 1 | $24.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.